Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
Frontiers in Pharmacology|April 21, 2020
Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol LevelsRemy Villette, Pukar Kc, Sophie Beliard, et al.Journal of Lipid Research|December 7, 2007
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjectsGiovanna Catalano, Emilie Duchene, Zélie Julia, et al.The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol effluxMaryse Guerin, Wilfried Le Goff, Eric Frisdal, et al.Scientific Reports|October 29, 2020
Inclusion of endophenotypes in a standard GWAS facilitate a detailed mechanistic understanding of genetic elements that control blood lipid levelsQianqian Zhang, Zexi Cai, Marie Lhomme, et al.Journal of the American Heart Association|July 31, 2024
Reduced Capacity of High-Density Lipoprotein to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy MenSophie Galier, Maryam Darabi, Feng Ma, et al.Atherosclerosis|June 8, 2002
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol effluxMaryse Guerin, Pascal Egger, Céline Soudant, et al.Journal of Lipid Research|October 5, 2002
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial stateMaryse Guerin, Pascal Egger, Céline Soudant, et al.Journal of the American Heart Association|November 25, 2016
Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to AtherosclerosisJulie Gall, Eric Frisdal, Randa Bittar, et al.The Journal of Biological Chemistry|July 16, 2011
Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory responseEric Frisdal, Philippe Lesnik, Maryline Olivier, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2008
Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathwayGiovanna Catalano, Zélie Julia, Eric Frisdal, et al.Pageof 7